Production (Stage)
So, one of the most prominent public historians of money and power publishes a piece for Bloomberg Opinion touting Bitcoin’s “store of value” characteristics the morning the world’s leading...
By Juan M. Villaverde On November 27, 202012:17 PM Eastern
Due to the Thanksgiving holiday, we shortened our normal trading week to six days ending midday Wednesday. Regardless of the condensed timeframe, the crypto market erupted higher.
Bitcoin (BTC,...
The recent news that Pfizer and Moderna have working COVID-19 vaccines hit investment markets like a bolt from the blue.
Investors everywhere rushed to figure out who would prosper most in a...
The Bitcoin (BTC, Tech/Adoption Grade “A-”) price will highlight most of the headlines you’ll see in mainstream financial media sources these days – and that’s a good thing.
As we often note,...
By Juan M. Villaverde On November 20, 202004:09 PM Eastern
Bitcoin (BTC, Tech/Adoption Grade “A-”) managed to surpass and sustain itself above the $18,000 price level during the seven-day trading week ended Thursday. As the largest and most established...
Last month, the People’s Bank of China gave its new digital yuan a trial run in Shenzhen, the border city adjacent to Hong Kong. It was a huge success.
More than 2 million people queued up for a...
“Frankly,” said Jim Druckenmiller on CNBC last Monday, “if the gold bet works, the Bitcoin bet will probably work better because it’s thinner, more illiquid and has a lot more beta to it.”
In...
By Juan M. Villaverde On November 13, 202002:57 PM Eastern
Bitcoin (BTC, Tech/Adoption Grade “A-”) continued climbing during the seven-day trading week ended Thursday, as it was able to cross and maintain itself above the $16,000 level. Unlike the last...
As Bitcoin (BTC, Tech/Adoption Grade “A-”) marches above $15,000, we see a broad shift in market sentiment is starting to take place — especially among big-foot investors.
That’s a big change....
Equity market indexes exploded today on news that Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) have developed a vaccine that’s more than 90% effective against COVID-19 “among those...